Vaxcyte (PCVX) Other Non-Current Liabilities (2019 - 2025)
Vaxcyte (PCVX) reported Other Non-Current Liabilities of $100000.0 for Q4 2025, little changed year-over-year from $100000.0 in Q4 2024, and little changed quarter-over-quarter from $100000.0 in Q4 2024.
Vaxcyte (PCVX) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
Vaxcyte (PCVX) has 7 years of Other Non-Current Liabilities data on file, last reported at $100000.0 in Q4 2025.
- Other Non-Current Liabilities for Q4 2025 came in at $100000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $100000.0 (changed 0.0% YoY), and the FY2025 annual result was $100000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities held at $100000.0 in Q4 2025 per PCVX's latest filing, from $100000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $103000.0 in Q1 2021 and troughed at $2000.0 in Q3 2023.
- A 5-year average of $68769.2 and a median of $93000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities tumbled 97.75% in 2023, then changed 0.0% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $96000.0 in 2021, then sank by 90.62% to $9000.0 in 2022, then slumped by 77.78% to $2000.0 in 2023, then soared by 4900.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
- Business Quant data shows PCVX's Other Non-Current Liabilities at $100000.0 in Q4 2025, $100000.0 in Q4 2024, and $2000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 89,000.00 |
| Jun 30, 2022 | 92,000.00 |
| Mar 31, 2022 | 93,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 98,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 103,000.00 |
| Dec 31, 2020 | 112,000.00 |
| Sep 30, 2020 | 128,000.00 |
| Jun 30, 2020 | 136,000.00 |
| Dec 31, 2019 | 242,000.00 |